A carregar...
Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection
Bedaquiline, a potent new therapy for drug-resistant tuberculosis, results in improved survival including in HIV patients with multidrug and extensively drug-resistant tuberculosis. In line with WHO recommendations, in South Africa and other low-income and middle-income settings, antiretroviral ther...
Na minha lista:
| Publicado no: | Lancet HIV |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7155388/ https://ncbi.nlm.nih.gov/pubmed/30846058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(19)30035-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|